Compounds > sb 203580
Page last updated: 2024-09-05

sb 203580 and Plasmacytoma

sb 203580 has been researched along with Plasmacytoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adams, JL; Feng, Y; Hansbury, M; Johnson, N; Semones, M; Winkler, J1

Other Studies

1 other study(ies) available for sb 203580 and Plasmacytoma

ArticleYear
Pyridinylimidazole inhibitors of Tie2 kinase.
    Bioorganic & medicinal chemistry letters, 2007, Sep-01, Volume: 17, Issue:17

    Topics: Animals; Cell Line, Tumor; Drug Design; Enzyme Inhibitors; Humans; Imidazoles; Inhibitory Concentration 50; Mice; Models, Chemical; Models, Molecular; Neoplasm Transplantation; p38 Mitogen-Activated Protein Kinases; Plasmacytoma; Pyridines; Receptor, TIE-2

2007